全文获取类型
收费全文 | 1054篇 |
免费 | 95篇 |
国内免费 | 14篇 |
专业分类
儿科学 | 26篇 |
妇产科学 | 11篇 |
基础医学 | 223篇 |
口腔科学 | 13篇 |
临床医学 | 77篇 |
内科学 | 271篇 |
皮肤病学 | 6篇 |
神经病学 | 61篇 |
特种医学 | 118篇 |
外科学 | 127篇 |
综合类 | 20篇 |
预防医学 | 80篇 |
眼科学 | 59篇 |
药学 | 46篇 |
中国医学 | 1篇 |
肿瘤学 | 24篇 |
出版年
2021年 | 10篇 |
2020年 | 8篇 |
2019年 | 9篇 |
2018年 | 15篇 |
2014年 | 14篇 |
2013年 | 19篇 |
2012年 | 31篇 |
2011年 | 28篇 |
2010年 | 24篇 |
2009年 | 29篇 |
2008年 | 56篇 |
2007年 | 32篇 |
2006年 | 46篇 |
2005年 | 38篇 |
2004年 | 26篇 |
2003年 | 35篇 |
2002年 | 31篇 |
2001年 | 28篇 |
2000年 | 32篇 |
1999年 | 31篇 |
1998年 | 28篇 |
1997年 | 22篇 |
1996年 | 36篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 25篇 |
1992年 | 20篇 |
1991年 | 15篇 |
1990年 | 16篇 |
1989年 | 26篇 |
1988年 | 23篇 |
1987年 | 16篇 |
1986年 | 10篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 8篇 |
1982年 | 12篇 |
1972年 | 15篇 |
1971年 | 11篇 |
1969年 | 10篇 |
1968年 | 15篇 |
1933年 | 16篇 |
1932年 | 9篇 |
1931年 | 8篇 |
1928年 | 17篇 |
1926年 | 21篇 |
1925年 | 15篇 |
1924年 | 13篇 |
1923年 | 22篇 |
1922年 | 19篇 |
排序方式: 共有1163条查询结果,搜索用时 15 毫秒
1.
Nicotine has been found to improve memory performance in a variety of tests including the radial-arm maze. Nicotine may have effects mediated by promoting the release of dopamine. The present study was conducted to determine the interactions of nicotine with D1 and D2 agonists. Rats were acutely administered nicotine, the D1 agonist SKF 38393, and D2/D3 agonist quinpirole, and nicotine together with each of these agonists. Nicotine significantly improved choice accuracy in the radial-arm maze. The D1 agonist SKF 38393 significantly impaired choice accuracy. Nicotine was effective in reversing this effect. The D2/D3 agonist quinpirole showed a trend toward potentiating the improvement in choice accuracy caused by 0.2 mg/kg (0.43 μmol/kg) of nicotine. These data show that, as with the nicotinic antagonist mecamylamine, there are significant interactions of dopamine systems with nicotine effects. © 1994 Wiley-Liss, Inc. 相似文献
2.
We studied the effect of imipramine (IMI) on thyroid releasing hormone (TRH)-induced urinary urgency as a way of investigating the mechanism of the beneficial effect of IMI on enuresis. In a double-blind study, 12 normal, healthy men between 21 and 39 yr of age ranked their urge to urinate at 30-sec intervals following IV injection of TRH (500 micrograms) or saline. The subjects then were randomly assigned to either IMI (1 mg/kg) or placebo groups for 10 days, and the procedure was repeated. Compared to saline, TRH produced a significant elevation in urinary urgency in all subjects. IMI did not significantly blunt TRH-induced urinary urgency. Thus, the mechanism by which IMI affects enuresis is likely not mediated at the level of the urinary urgency induced by TRH. 相似文献
3.
可逆性胆硷酯酶抑制剂二甲氨基甲酸-5-二氢吲哚酯的合成 总被引:1,自引:0,他引:1
为了深入研究催醒宁类化合物的结构与抑酶活性的关系,设计合成了-系列1-,3-或5-位不同取代的二氢吲哚类衍生物(中间体和终产物共24个新化合物)。中间体1,3-二甲基-5-烷氧基-2-二氢吲哚酮(A)的C3烷化。采用相转移催化方法进行;反应中还分离到三个副产物(Ⅶ~Ⅸ)。初筛结果表明:这些化合物大多有较强的抑酶活性;1,3-或5-位取代基的改变均明显影响其活性。 相似文献
4.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
5.
Patricia P Katz Edward H Yelin Mark D Eisner Paul D Blanc 《Annals of allergy, asthma & immunology》2002,89(3):251-258
BACKGROUND: Perceived control of certain chronic conditions influences health status outcomes. OBJECTIVE: To explore the impact of perceived control of asthma on asthma-specific and generic health status outcomes among adults with asthma. Perceived control was defined as individuals' perceptions of their ability to deal with asthma and its exacerbations. METHODS: Data were drawn from the baseline and first two followups of a longitudinal study of adults with asthma surveyed by telephone at 18-month intervals. An 11-item questionnaire (Perceived Control of Asthma Questionnaire [PCAQ]) was developed and validated. RESULTS: The PCAQ demonstrated high internal consistency (Cronbach's alpha = 0.79). Greater perceived control was associated with less severe asthma, greater asthma self-efficacy, lower perceived asthma severity, lower perceived danger from asthma, and greater perceived usefulness of asthma medicines. Greater perceived control was significantly associated with better asthma-specific quality of life concurrently and 18 and 36 months later, after controlling for demographics, smoking, and severity of asthma. Greater perceived control as also significantly associated with generic mental health outcomes concurrently and 18 and 36 months later, after controlling for covariates. Perceived control was associated with physical function concurrently and 18 months later, but not 36 months later. CONCLUSIONS: The PCAQ is a reliable and valid measure of perceived control of asthma. Perceived control of asthma was associated with both asthma-specific and generic health status outcomes, concurrently and predictively. If perceived control could be modified, better outcomes, particularly better psychologic outcomes, might be achieved for individuals with asthma. 相似文献
6.
7.
Edward Yelin Patricia Katz John Balmes Laura Trupin Gillian Earnest Mark Eisner Paul Blanc 《Journal of occupational medicine and toxicology (London, England)》2006,1(1):2-9
Objective
To estimate the duration of work life among persons reporting a physician's diagnosis of COPD, asthma, or rhinitis compared to those with select non-respiratory conditions or none and to delineate the factors associated with continuance of employment. 相似文献8.
Robert L Eisner Randolph E Patterson 《Journal of nuclear medicine》2007,48(11):1912-3; author reply 1913-4
9.
10.
Mark D Eisner Patricia P Katz Gretchen Lactao Carlos Iribarren 《Annals of allergy, asthma & immunology》2005,94(5):566-574
BACKGROUND: Psychological disorders, including depression, are common in adults with asthma. Although depression is treatable, its impact on longitudinal asthma outcomes is not clear. OBJECTIVE: To elucidate the impact of depressive symptoms on patient-centered outcomes and emergency health care use in adults with asthma. METHODS: We conducted a prospective cohort study of 743 adults with asthma who were recruited after hospitalization for asthma. Depressive symptoms were defined as having a score of 16 or more on the Center for Epidemiologic Studies Depression Scale. We examined the impact of depressive symptoms on patient-centered outcomes (validated severity-of-asthma score, Marks Asthma Quality of Life Questionnaire, and 12-Item Short-Form Health Survey physical component summary score) and on future emergency health care use for asthma ascertained from computerized databases. RESULTS: The prevalence of depressive symptoms was 18% (95% confidence interval [CI], 15%-21%) among adults with asthma. Depressive symptoms were associated with greater severity-of-asthma scores after controlling for age, sex, race/ ethnicity, educational attainment, and cigarette smoking (mean score increment, 2.6 points; 95% CI, 1.8-3.4 points). Furthermore, depressive symptoms were associated with poorer asthma-specific quality of life (mean score increment, 19.9 points; 95% CI, 17.7-22.1 points) and poorer physical health status (mean score decrement, 3.7 points; 95% CI, 1.5-5.8 points). Depressive symptoms were associated with a greater longitudinal risk of hospitalization for asthma (hazard ratio, 1.34; 95% CI, 0.98-1.84). After controlling for differences in preventive care for asthma, the relationship was stronger (hazard ratio, 1.45; 95% CI, 1.05-2.0). CONCLUSION: Depressive symptoms are common in adults with asthma and are associated with poorer health outcomes, including greater asthma severity and risk of hospitalization for asthma. 相似文献